Literature DB >> 6870274

Metabolic behavior of acetyl glyceryl ether phosphorylcholine on interaction with rabbit platelets.

G Pieroni, D J Hanahan.   

Abstract

The metabolic fate of 1-O-[3H]alkyl-2-acetyl-sn-glycero-3-phosphorylcholine ([3H]-AGEPC) upon interaction with rabbit platelets was investigated. [3H]AGEPC was converted to a product identified as the long-chain fatty acyl analog. The reaction was unaffected by extracellular calcium. After a lag time of 30 to 60 s the kinetics of the conversion was linear. The rate of the reaction was found to be a function of platelet and AGEPC concentrations. Of the [3H]AGEPC (10(-9) M) 85 +/- 5% was processed into the-long chain fatty acyl analog within 1 h when incubated at 37 degrees C with a 1.25 X 10(9) platelets per milliliter suspension. A maximal number of 1200 to 3600 [3H]AGEPC molecules were converted to the long-chain fatty acyl derivative per minute per platelet in the presence of 2 mM EDTA. Under similar conditions the 1-O-[3H]alkyl-2-(lyso)-sn-glycero-3-phosphorylcholine ([3H]lysoGEPC) also was transformed to a comparable long-chain fatty acyl derivative at a much slower rate and to a lower extent. No significant increase in lysoGEPC was noted in incubation mixtures containing [3H]AGEPC. The possible direct transacylation of AGEPC upon interaction with platelets is discussed as well as the possible involvement of this reaction in directly triggering the platelet response to AGEPC stimuli.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6870274     DOI: 10.1016/0003-9861(83)90236-9

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  9 in total

1.  Binding and metabolism of platelet-activating factor by human neutrophils.

Authors:  J T O'Flaherty; J R Surles; J Redman; D Jacobson; C Piantadosi; R L Wykle
Journal:  J Clin Invest       Date:  1986-08       Impact factor: 14.808

2.  Occupancy of platelet receptors for platelet-activating factor in patients with septicemia.

Authors:  F Lopez Diez; M L Nieto; S Fernandez-Gallardo; M A Gijon; M Sanchez Crespo
Journal:  J Clin Invest       Date:  1989-05       Impact factor: 14.808

3.  Platelet-activating factor (PAF-acether) induces high- and low-affinity binding of fibrinogen to human platelets via independent mechanisms.

Authors:  E Kloprogge; J W Akkerman
Journal:  Biochem J       Date:  1986-12-01       Impact factor: 3.857

4.  The role of Ca2+ in regulating the catabolism of PAF-acether (1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine) in rabbit platelets.

Authors:  L Touqui; A M Shaw; C Dumarey; C Jacquemin; B B Vargaftig
Journal:  Biochem J       Date:  1987-01-15       Impact factor: 3.857

5.  Human platelets stimulated by thrombin produce platelet-activating factor (1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine) when the degrading enzyme acetyl hydrolase is blocked.

Authors:  L Touqui; M Hatmi; B B Vargaftig
Journal:  Biochem J       Date:  1985-08-01       Impact factor: 3.857

6.  Arachidonyl transfer from diacyl phosphatidylcholine to ether phospholipids in rat platelets.

Authors:  O Colard; M Breton; G Bereziat
Journal:  Biochem J       Date:  1984-09-15       Impact factor: 3.857

7.  Human platelets release a paf-acether: acetylhydrolase similar to that in plasma.

Authors:  R Korth; J Bidault; R Palmantier; J Benveniste; E Ninio
Journal:  Lipids       Date:  1993-03       Impact factor: 1.880

8.  Binding kinetics of PAF-acether (1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine) to intact human platelets.

Authors:  E Kloprogge; J W Akkerman
Journal:  Biochem J       Date:  1984-11-01       Impact factor: 3.857

9.  Metabolism of platelet-activating factor (PAF; 1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine) and lyso-PAF (1-O-alkyl-2-lyso-sn-glycero-3-phosphocholine) by cultured rat Kupffer cells.

Authors:  W Chao; A Siafaka-Kapadai; D J Hanahan; M S Olson
Journal:  Biochem J       Date:  1989-07-01       Impact factor: 3.857

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.